Xiao Hu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Xiao Hu has a total of 30 co-authors. Here are the top co-authors by number of shared publications:
- Bin Wang
Department of Gastroenterology, Chongqing Key Laboratory of Digestive Malignancies, Daping Hospital, Chongqing, China
13 shared publications - Dongfeng Chen
Department of Gastroenterology, Chongqing Key Laboratory of Digestive Malignancies, Daping Hospital, Army Medical University (Third Military Medical University), Chongqing, China
13 shared publications - Fan Li
Gastric and Colorectal Surgery Division, Department of General Surgery, Army Medical Center (Daping Hospital), Army Medical University, Chongqing, China
13 shared publications - Hui-Yan Luo
Department of Medical Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University, Guangzhou, PR China
13 shared publications - Jianwu Zhu
Cancer Center, Daping Hospital, Army Medical University, Chongqing, P.R. China
13 shared publications - Jinyang Li
Department of Gastroenterology, Chongqing Key Laboratory of Digestive Malignancies, Daping Hospital, Army Medical University (Third Military Medical University), Chongqing, China
13 shared publications
Latest Publications
- Open Access
- 6 January 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Table S2 from Intestinal Subtype as a Biomarker of Response to Neoadjuvant Immunochemotherapy in Locally Advanced Gastric Adenocarcinoma: Insights from a Prospective Phase II Trial
Surgical and pathological results
- 6 January 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S2 from Intestinal Subtype as a Biomarker of Response to Neoadjuvant Immunochemotherapy in Locally Advanced Gastric Adenocarcinoma: Insights from a Prospective Phase II Trial
Surgical and pathological results
- Open Access
- 6 January 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S3 from Intestinal Subtype as a Biomarker of Response to Neoadjuvant Immunochemotherapy in Locally Advanced Gastric Adenocarcinoma: Insights from a Prospective Phase II Trial
Identification of malignant and non-malignant epithelial cells in gastric cancer
- 6 January 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S3 from Intestinal Subtype as a Biomarker of Response to Neoadjuvant Immunochemotherapy in Locally Advanced Gastric Adenocarcinoma: Insights from a Prospective Phase II Trial
Identification of malignant and non-malignant epithelial cells in gastric cancer
- Open Access
- 6 January 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Table S4 from Intestinal Subtype as a Biomarker of Response to Neoadjuvant Immunochemotherapy in Locally Advanced Gastric Adenocarcinoma: Insights from a Prospective Phase II Trial
Baseline characteristics associated with pathological response
- 6 January 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S4 from Intestinal Subtype as a Biomarker of Response to Neoadjuvant Immunochemotherapy in Locally Advanced Gastric Adenocarcinoma: Insights from a Prospective Phase II Trial
Baseline characteristics associated with pathological response
- Open Access
- 6 January 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Table S3 from Intestinal Subtype as a Biomarker of Response to Neoadjuvant Immunochemotherapy in Locally Advanced Gastric Adenocarcinoma: Insights from a Prospective Phase II Trial
Neoadjuvant and adjuvant treatment-related adverse events
- 6 January 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S3 from Intestinal Subtype as a Biomarker of Response to Neoadjuvant Immunochemotherapy in Locally Advanced Gastric Adenocarcinoma: Insights from a Prospective Phase II Trial
Neoadjuvant and adjuvant treatment-related adverse events
- Open Access
- 6 January 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Methods S1 from Intestinal Subtype as a Biomarker of Response to Neoadjuvant Immunochemotherapy in Locally Advanced Gastric Adenocarcinoma: Insights from a Prospective Phase II Trial
Supplementary Information on Materials and Methods
- 6 January 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Methods S1 from Intestinal Subtype as a Biomarker of Response to Neoadjuvant Immunochemotherapy in Locally Advanced Gastric Adenocarcinoma: Insights from a Prospective Phase II Trial
Supplementary Information on Materials and Methods
- Open Access
- 6 January 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Table S9 from Intestinal Subtype as a Biomarker of Response to Neoadjuvant Immunochemotherapy in Locally Advanced Gastric Adenocarcinoma: Insights from a Prospective Phase II Trial
Representativeness of Study Participants
- 6 January 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S9 from Intestinal Subtype as a Biomarker of Response to Neoadjuvant Immunochemotherapy in Locally Advanced Gastric Adenocarcinoma: Insights from a Prospective Phase II Trial
Representativeness of Study Participants
- Open Access
- 6 January 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S4 from Intestinal Subtype as a Biomarker of Response to Neoadjuvant Immunochemotherapy in Locally Advanced Gastric Adenocarcinoma: Insights from a Prospective Phase II Trial
Marker genes for immune and stromal cell subtypes
- 6 January 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S4 from Intestinal Subtype as a Biomarker of Response to Neoadjuvant Immunochemotherapy in Locally Advanced Gastric Adenocarcinoma: Insights from a Prospective Phase II Trial
Marker genes for immune and stromal cell subtypes
- Open Access
- 6 January 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S2 from Intestinal Subtype as a Biomarker of Response to Neoadjuvant Immunochemotherapy in Locally Advanced Gastric Adenocarcinoma: Insights from a Prospective Phase II Trial
Single cell transcriptome analysis of gastric adenocarcinoma tissues
- 6 January 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S2 from Intestinal Subtype as a Biomarker of Response to Neoadjuvant Immunochemotherapy in Locally Advanced Gastric Adenocarcinoma: Insights from a Prospective Phase II Trial
Single cell transcriptome analysis of gastric adenocarcinoma tissues